Cargando…

Can biological markers improve the management of breast cancer patients?

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374516/ https://www.ncbi.nlm.nih.gov/pubmed/10817494 http://dx.doi.org/10.1054/bjoc.2000.1159

Ejemplares similares

Minimal breast cancer: evaluation of histology and biological marker expression
por: Dublin, E A, et al.
Publicado: (1999)

Biological markers: maintaining standards
Publicado: (2000)

Markers of bone turnover for the management of patients with bone metastases from prostate cancer
por: Garnero, P, et al.
Publicado: (2000)

Biologic markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size
por: Sauter, E R, et al.
Publicado: (1999)

The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy
por: Nicolini, A, et al.
Publicado: (1999)

Number of apoptotic cells as a prognostic marker in invasive breast cancer
por: Jong, J S de, et al.
Publicado: (2000)

Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer
por: Merrie, A E H, et al.
Publicado: (1999)

Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer
por: Magdalena, C, et al.
Publicado: (2000)

The role of tumour markers in improving the accuracy of conventional chest X-ray and liver echography in the post-operative detection of thoracic and liver metastases from breast cancer
por: Nicolini, A, et al.
Publicado: (2000)

The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis
por: Clark, J W, et al.
Publicado: (1999)

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF
por: Poikonen, P, et al.
Publicado: (1999)

Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer
por: Houston, S J, et al.
Publicado: (1999)

Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia
por: Infante-Rivard, C, et al.
Publicado: (2000)

Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy
por: Demetri, G D
Publicado: (2001)

Hormonally-regulated proteins in breast secretions are markers of target organ sensitivity
por: Harding, C, et al.
Publicado: (2000)

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness
por: Wärnberg, F, et al.
Publicado: (2001)

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up
por: Harbeck, N, et al.
Publicado: (1999)

Biological ageing and frailty markers in breast cancer patients
por: Brouwers, Barbara, et al.
Publicado: (2015)

Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer
por: Paradiso, A, et al.
Publicado: (2001)

Mental training can improve physical activity behavior in adolescent girls
por: Najafabadi, Mahboubeh Ghayour, et al.
Publicado: (2017)

Induced Expression of Cancer Stem Cell Markers ALDH1A3 and Sox-2 in Hierarchical Reconstitution of Apoptosis-resistant Human Breast Cancer Cells
por: Kashii-Magaribuchi, Karin, et al.
Publicado: (2016)

Screening breast cancer patients for Norwegian ATM mutations
por: Laake, K, et al.
Publicado: (2000)

Chromosomal radiosensitivity as a marker of predisposition to common cancers?
por: Baria, K, et al.
Publicado: (2001)

An educational strategy for improving knowledge about breast and cervical cancer prevention among Mexican middle school students
por: Calderón- Garcidueñas, Ana Laura, et al.
Publicado: (2015)

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
por: Yazici, H, et al.
Publicado: (2000)

Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer
por: Simms, M S, et al.
Publicado: (2000)

p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer
por: Phillips, H A, et al.
Publicado: (2000)

Is Monitoring Mean Platelet Volume Necessary in Breast Cancer Patients?
por: Taskaynatan, Halil, et al.
Publicado: (2018)

Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines
por: Perks, C M, et al.
Publicado: (1999)

Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study
por: Matthews, C E, et al.
Publicado: (2001)

Brain metastasis reirradiation in patients with advanced breast cancer
por: Huang, Zhou, et al.
Publicado: (2017)

The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer
por: Cook, A M, et al.
Publicado: (2000)

Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients
por: Dowling, Paul, et al.
Publicado: (2014)

Cardiac impacts of postoperative radiotherapy for breast cancer in Japanese patients
por: Segawa, Erika, et al.
Publicado: (2023)

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
por: Verhoog, L C, et al.
Publicado: (2000)

Can Deliberately Incomplete Gene Sample Augmentation Improve a Phylogeny Estimate for the Advanced Moths and Butterflies (Hexapoda: Lepidoptera)?
por: Cho, Soowon, et al.
Publicado: (2011)

Cerebrospinal fluid inflammatory markers in patients with Listeria monocytogenes meningitis
por: Koopmans, Merel M., et al.
Publicado: (2014)

Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients
por: Papworth, R, et al.
Publicado: (2001)

Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation
por: Hirata, Kimiko, et al.
Publicado: (2017)

A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population
por: Jupe, Eldon R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ebq3f697677c32meh2snt33bam